Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib
Clinical trial NCT03592199 · UNKNOWN
Trial details
- NCT number
- NCT03592199
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-11
- Primary completion
- 2019-12-11
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.